CN Patent

CN103153311A — 布鲁顿酪氨酸激酶(btk)抑制剂的应用

Assigned to Pharmacyclics LLC · Expires 2013-06-12 · 13y expired

What this patent protects

本发明公开用于治疗癌症的方法，包含：a.向个体施用Btk抑制剂，其足以造成血液中由免疫表型所界定的淋巴细胞亚群的增加或出现；b.测定一种或多种淋巴细胞亚群中的一种或多种生物标志物的表达概貌；以及c.基于测定的表达概貌施用第二试剂。

USPTO Abstract

本发明公开用于治疗癌症的方法，包含：a.向个体施用Btk抑制剂，其足以造成血液中由免疫表型所界定的淋巴细胞亚群的增加或出现；b.测定一种或多种淋巴细胞亚群中的一种或多种生物标志物的表达概貌；以及c.基于测定的表达概貌施用第二试剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN103153311A
Jurisdiction
CN
Classification
—
Expires
2013-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacyclics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.